Mescaline is a naturally occurring psychedelic alkaloid found in several cactus species, most famously peyote (Lophophora williamsii) in the southwestern United States and northern Mexico, and the San Pedro cactus (Echinopsis pachanoi) along the Andes in South America. It was the first psychedelic compound isolated and chemically identified, extracted from peyote in 1897 by German chemist Arthur Heffter and synthesised in the lab in 1919 by Ernst Späth. Mescaline use in Indigenous ceremonial contexts predates its Western isolation by at least 5,700 years, with peyote remains found at archaeological sites in Texas dating to that period.
This article covers what mescaline is and where it comes from, the effects it produces on the mind and body, how long those effects last, the risks and side effects, the question of addiction, what mescaline looks like in its various forms, the dangers of mixing it with other drugs, the legal status, the therapeutic research that is starting to take shape, and how it compares with related psychedelics like psilocybin and LSD.
Mescaline is a phenethylamine, a chemical family that includes neurotransmitters like dopamine and norepinephrine. Unlike psilocybin and LSD, which are tryptamines, mescaline has a different molecular structure that nonetheless produces a comparable psychedelic experience by acting on the same brain pathways. According to the National Institute on Drug Abuse, “mescaline is a chemical compound found in peyote, a small cactus native to America’s southwest.”
The compound occurs naturally in three cacti of practical interest. Peyote contains the highest mescaline concentration by dry weight, typically 3 to 6 percent. The San Pedro cactus contains roughly 0.3 to 2 percent, depending on cultivar and growing conditions. The closely related Peruvian torch (Echinopsis peruviana) contains broadly similar amounts to San Pedro. All three have a long history of ceremonial use; peyote in particular is sacred to the Native American Church, whose members hold a federal exemption to use it in the United States.
Mescaline produces a classic psychedelic experience: visual changes (intensified colour, geometric patterns, slow waves of motion across surfaces), altered sense of time, amplified emotional response, and a feeling of unity between the self and surroundings. The subjective effects often include a slow, dreamlike quality that distinguishes mescaline from the more electric LSD experience and the more introspective psilocybin one.
Physically, mescaline raises body temperature slightly, dilates pupils, can cause nausea (peyote in particular is famously bitter and often induces vomiting in the first hour), and produces mild increases in heart rate and blood pressure. Most physical effects are similar to other classic psychedelics; the distinguishing feature is the long, smooth arc of the experience rather than the more compressed peak of psilocybin.
Mescaline is the long-runner of the classic psychedelics. A standard dose produces effects lasting ten to twelve hours, considerably longer than psilocybin’s four to six hours and roughly comparable to a long LSD experience. Onset is slower as well: first effects typically appear forty-five to ninety minutes after ingestion, peak intensity falls between two and four hours in, and the gentle return to baseline takes another five to seven hours.
The long duration is one reason mescaline experiences are typically planned as full-day events with a sober companion or trip sitter present. It is also why ceremonial peyote sessions, particularly those of the Native American Church, traditionally extend through the night.
In its pure form, mescaline is a white or off-white crystalline powder. In its natural form, it is consumed as fresh or dried cactus material. Peyote “buttons” are the dried, rounded tops of the cactus, eaten directly or steeped as tea. San Pedro and Peruvian torch are usually peeled, the green skin and a thin underlying layer simmered into a bitter brew, often filtered to remove plant fibre. Synthetic mescaline sulphate or hydrochloride is sometimes encountered as a powder or pressed into tablets, although it is far less common on the recreational market than psilocybin or LSD.
Doses vary by form. A moderate oral dose of pure mescaline is around 200 to 400 milligrams. The equivalent in dried peyote buttons is roughly 27 to 54 grams. San Pedro doses are larger by weight because of the lower alkaloid concentration, usually 100 to 300 grams of dried cactus or a brewed extract from a comparable amount of fresh material.
The most common acute side effects are nausea and vomiting, particularly with peyote, which contains other bitter alkaloids alongside mescaline. The combination of long duration and intense subjective effects raises the risk of a difficult experience for anyone unprepared, especially during the slow onset when the experience is building. Bad trips on mescaline tend to be long and weighty rather than fast and fragmented, which makes a trusted sitter and a quiet, comfortable setting particularly important.
Physical risks are generally mild but worth noting: raised heart rate and blood pressure mean mescaline is not safe for people with significant cardiovascular conditions. It can also lower seizure threshold in people prone to seizures. The risk of true overdose from oral mescaline alone is low, but the experience itself is intense enough that poor judgement during the trip can produce real-world harm.
Mescaline is not considered addictive in the conventional sense. It does not produce the dopamine reward pattern that drives compulsive use of stimulants or opioids, and tolerance builds quickly: a second dose taken within a few days of the first produces a substantially weaker experience. That natural tolerance, combined with the day-long duration of each session and the often-uncomfortable nausea, makes daily or even weekly mescaline use practically rare.
The broader pattern of any psychedelic substance still warrants attention. Drug abuse, in the sense of using a substance in a way that damages a life, is possible with any compound that strongly alters perception, even one with a low physical addiction profile.
Mixing mescaline with other drugs is the most consistent recommendation to avoid across harm-reduction sources. Particularly dangerous combinations include monoamine oxidase inhibitors (MAOIs), which can amplify mescaline’s effects unpredictably and raise blood pressure to dangerous levels, and lithium, which has been associated with seizures when combined with classic psychedelics. SSRIs blunt mescaline’s effects without eliminating risk, which sometimes leads users to take larger doses, compounding the underlying interaction. Alcohol, cannabis, and stimulants all interact in less specific but still problematic ways: alcohol can increase nausea, cannabis can intensify and destabilise the experience, and stimulants stack the cardiovascular load.
Mescaline is a controlled substance in most countries. In Canada, it is listed under Schedule III of the Controlled Drugs and Substances Act, alongside psilocybin, psilocin, LSD, and other classic hallucinogens. Possession, production, and trafficking carry criminal penalties. The peyote cactus itself is specifically exempted from Canadian control, which creates an unusual legal situation in which the plant is legal but the alkaloid it produces is not.
In the United States, mescaline and peyote are both Schedule I substances, with the long-standing exemption for ceremonial peyote use by members of the Native American Church. San Pedro and other mescaline-containing cacti other than peyote are legal to grow as ornamental plants in many US states, but the extraction or consumption of mescaline from them is not.
Therapeutic research on mescaline is much smaller than the parallel work on psilocybin and MDMA, partly because of the long duration of the experience (which makes clinical sessions logistically difficult) and partly because of the regulatory complications around peyote. The early phase of modern psychedelic research, in the 1950s and 1960s, included mescaline studies for alcoholism and depression, with mixed results.
Contemporary interest is renewed but cautious. The National Center for Complementary and Integrative Health notes that psilocybin combined with psychotherapy may be safe and effective for improving anxiety, depression, and existential distress; whether mescaline produces comparable results in a comparable framework remains an open question that current trials are only beginning to address.
The closest pharmacological neighbours are the other classic serotonergic psychedelics: psilocybin (and the magic mushrooms that produce it), LSD, DMT (and ayahuasca), and 2C-B and related synthetic phenethylamines. All of these act primarily on the 5-HT2A serotonin receptor and produce comparable broad categories of effect. The practical differences are duration, onset, intensity, and quality of the experience. Mescaline runs the longest of the four; DMT runs the shortest; psilocybin sits in the middle; LSD overlaps with mescaline on duration but is structurally more electric in subjective character.
Globally, dried San Pedro cactus and San Pedro tea are the most common forms because the cactus grows readily and contains usable mescaline concentrations. Peyote is more famous historically but has been overharvested in the wild and is increasingly difficult to obtain outside Indigenous ceremonial use. Pure synthetic mescaline is rare on the recreational market.
Mescaline experiences last roughly twice as long, have a slower onset, and are often described as warmer and more emotional than psilocybin’s more visual and cognitive arc. The two compounds act on the same brain receptors but produce subjectively distinct experiences.
Yes. Peyote is slow-growing (a wild plant takes ten to thirty years to reach maturity) and has been overharvested in its native range in Texas and northern Mexico. Conservation efforts focus on protecting the wild population and supporting cultivation for Indigenous ceremonial use.
Hallucinogen Persisting Perception Disorder, the formal name for psychedelic flashbacks, can occur with mescaline as with any classic psychedelic. It is rare and is not well understood; reported risk factors include pre-existing anxiety conditions, high doses, and frequent use.
Both contain mescaline, but peyote (Lophophora williamsii) is a small, slow-growing button cactus native to the Chihuahuan Desert, while San Pedro (Echinopsis pachanoi) is a tall, fast-growing columnar cactus from the Andes. Peyote is more potent by weight, more difficult to grow, and more restricted legally. San Pedro is easier to cultivate and produces a milder experience per gram of plant material.
